+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 123 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 4375410
Description Jump to:
The global clinical trial supplies market size is expected to reach USD 3.4 billion by 2030, expanding at 6.5% CAGR from 2023 to 2030, according to this report. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights

  • Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 52.7% revenue share in 2022. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
  • Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 6.8% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
  • Biologics are expected to witness the fastest growth at 6.7% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
  • In terms of therapeutic use, oncology dominated the market with a revenue share of 38.8% in 2022. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Clinical Phase
1.1.3. Product & Services
1.1.4. End Use
1.1.5. Therapeutic Area
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expansion of clinical trials sites
3.2.1.2. Growing R&D in biologics and biosimilar
3.2.1.3. Advancements in supply chain technology
3.2.2. Market Restraint Analysis
3.2.2.1. Presence of stringent regulatory policies
3.2.2.2. High Possibility of Counterfeiting Drugs
3.3. Clinical Trial Supplies Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis
4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030
4.3.1. Phase I
4.3.1.1. Phase I Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
4.3.2. Phase II
4.3.2.1. Phase II Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
4.3.3. Phase III
4.3.3.1. Phase III Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
4.3.4. Phase IV
4.3.4.1. Phase IV Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
4.3.5. Others
4.3.5.1. Others market, 2018 to 2030 (USD Billion)
Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis
5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030
5.3.1. Manufacturing
5.3.1.1. Manufacturing Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
5.3.2. Storage & Distribution
5.3.2.1. Storage & Distribution Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
5.3.3. Supply Chain Management
5.3.3.1. Supply Chain Management Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis
6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
6.3.1. Oncology
6.3.1.1. Oncology clinical trial supplies market 2018 to 2030 (USD Billion)
6.3.2. CNS
6.3.2.1. CNS clinical trial supplies market 2018 to 2030 (USD Billion)
6.3.3. Cardiovascular
6.3.3.1. Cardiovascular clinical trial supplies market 2018 to 2030 (USD Billion)
6.3.4. Infectious disease
6.3.4.1. Infectious disease clinical trial supplies market 2018 to 2030 (USD Billion)
6.3.5. Metabolic disorders
6.3.5.1. Metabolic Disorders Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
6.3.6. Others
6.3.6.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)
Chapter 7. Clinical Trial Supplies Market: End-use Estimates & Trend Analysis
7.1. Clinical Trial Supplies Market, By End-use: Segment Dashboard
7.2. Clinical Trial Supplies Market, By End-use: Movement Analysis
7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End-use, 2018 - 2030
7.3.1. Pharmaceutical
7.3.1.1. Pharmaceutical Clinical trial supplies market 2018 to 2030 (USD Billion)
7.3.2. Biologics
7.3.2.1. Biologics clinical trial supplies market 2018 to 2030 (USD Billion)
7.3.3. Medical Devices
7.3.3.1. Medical devices clinical trial supplies market 2018 to 2030 (USD Billion)
7.3.4. Others
7.3.4.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)
Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2022 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Billion)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. U.S. market estimates and forecasts, 2018 - 2030
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Canada market estimates and forecasts, 2018 - 2030
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. UK market estimates and forecasts, 2018 - 2030
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Germany market estimates and forecasts, 2018 - 2030
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. France market estimates and forecasts, 2018 - 2030
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Italy market estimates and forecasts, 2018 - 2030
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Spain market estimates and forecasts, 2018 - 2030
8.5.6. Denmark
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Denmark market estimates and forecasts, 2018 - 2030
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Sweden market estimates and forecasts, 2018 - 2030
8.5.8. Norway
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Norway market estimates and forecasts, 2018 - 2030
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Japan market estimates and forecasts, 2018 - 2030
8.6.2. India
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. India market estimates and forecasts, 2018 - 2030
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. China market estimates and forecasts, 2018 - 2030
8.6.4. South Korea
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. South Korea market estimates and forecasts, 2018 - 2030
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Australia market estimates and forecasts, 2018 - 2030
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. Thailand market estimates and forecasts, 2018 - 2030
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Brazil market estimates and forecasts, 2018 - 2030
8.7.2. Mexico
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Mexico Market estimates and forecasts, 2018 - 2030
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Argentina market estimates and forecasts, 2018 - 2030
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. South Africa market estimates and forecasts, 2018 - 2030
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. UAE market estimates and forecasts, 2018 - 2030
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Innovators
9.1.2. Market Leaders
9.1.3. Emerging Players
9.1.4. Company Market Share Analysis, 2022
9.2. Company Profiles
9.2.1. Almac Group
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Service benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Biocair
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Service benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Catalent, Inc.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Service benchmarking
9.2.3.4. Strategic initiatives
9.2.4. KLIFO
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Service benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Movianto
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Service benchmarking
9.2.5.4. Strategic initiatives
9.2.6. PCI Pharma Services
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Service benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Sharp Services, LLC
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Service benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Thermo Fisher Scientific, Inc.
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Service benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Marken
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Service benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Paraxel International Corporation
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Service benchmarking
9.2.10.4. Strategic initiatives
List of Tables
Table 1: List of Abbreviations
Table 2: North America clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 3: North America clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 4: North America clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 5: North America clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 6: US clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 7: US clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 8: US clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 9: US clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 10: Canada clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 11: Canada clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 12: Canada clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 13: Canada clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 14: Europe clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 15: Europe clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 16: Europe clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 17: Europe clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 18: UK clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 19: UK clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 20: UK clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 21: UK clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 22: Germany clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 23: Germany clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 24: Germany clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 25: Germany clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 26: France clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 27: France clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 28: France clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 29: France clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 30: Italy clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 31: Italy clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 32: Italy clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 33: Italy clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 34: Spain clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 35: Spain clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 36: Spain clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 37: Spain clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 38: Denmark clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 39: Denmark clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 40: Denmark clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 41: Denmark clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 42: Sweden clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 43: Sweden clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 44: Sweden clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 45: Sweden clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 46: Norway clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 47: Norway clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 48: Norway clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 49: Norway clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 50: Asia Pacific clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 51: Asia Pacific clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 52: Asia Pacific clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 53: Asia Pacific clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 54: Japan clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 55: Japan clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 56: Japan clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 57: Japan clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 58: China clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 59: China clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 60: China clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 61: China clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 62: India clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 63: India clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 64: India clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 65: India clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 66: Australia clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 67: Australia clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 68: Australia clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 69: Australia clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 70: South Korea clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 71: South Korea clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 72: South Korea clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 73: South Korea clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 74: Thailand clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 75: Thailand clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 76: Thailand clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 77: Thailand clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 78: Latin America clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 79: Latin America clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 80: Latin America clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 81: Latin America clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 82: Brazil clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 83: Brazil clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 84: Brazil clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 85: Brazil clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 86: Mexico clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 87: Mexico clinical trials supply chain management market, by type, 2018-2030 (USD Billion)
Table 88: Mexico clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 89: Mexico clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 90: MEA clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 91: MEA clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 92: MEA clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 93: MEA clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 94: South Africa clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 95: South Africa clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 96: South Africa clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 97: South Africa clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 98: Saudi Arabia clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 99: Saudi Arabia clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 100: Saudi Arabia clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 101: Saudi Arabia clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 102: UAE clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 103: UAE clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 104: UAE clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 105: UAE clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
Table 106: Kuwait clinical trial supplies market, by product and services, 2018-2030 (USD Billion)
Table 107: Kuwait clinical trial supplies market, by end-use, 2018-2030 (USD Billion)
Table 108: Kuwait clinical trial supplies market, by therapeutics use, 2018-2030 (USD Billion)
Table 109: Kuwait clinical trial supplies market, by clinical phases, 2018-2030 (USD Billion)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value chain-based sizing & forecasting
Fig. 6: QFD modeling for market share assessment
Fig. 7: Market summary (Figures in USD Billion, 2022)
Fig. 8: Market trends & outlook
Fig. 9: Clinical trial supplies market: Market segmentation
Fig. 10: Clinical trial supplies market revenue, (USD Billion), 2018-2030
Fig. 11: Clinical trial supplies: Porter’s analysis
Fig. 12: Clinical trial supplies: PESTEL analysis
Fig. 13: Clinical trial supplies market phase outlook key takeaways
Fig. 14: Clinical trial supplies market: Phase movement analysis
Fig. 15: Phase I market, 2018-2030 (USD Billion)
Fig. 16: Phase II market, 2018-2030 (USD Billion)
Fig. 17: Phase III market, 2018-2030 (USD Billion)
Fig. 18: Others market, 2018-2030 (USD Billion)
Fig. 19: Clinical trial supplies market product/service outlook key takeaways
Fig. 20: Clinical trial supplies market: Product/Service movement analysis
Fig. 21: Manufacturing market, 2018-2030 (USD Billion)
Fig. 22: Storage & distribution market, 2018-2030 (USD Billion)
Fig. 23: Cold chain-based storage & distribution market, 2018-2030 (USD Billion)
Fig. 24: Non-cold chain-based storage & distribution market, 2018-2030 (USD Billion)
Fig. 25: Supply chain management market, 2018-2030 (USD Billion)
Fig. 26: Clinical trial supplies market end-use outlook key takeaways
Fig. 27: Clinical trial supplies market: End-use movement analysis
Fig. 28: Pharmaceuticals market, 2018-2030 (USD Billion)
Fig. 29: Biologics market, 2018-2030 (USD Billion)
Fig. 30: Medical device market, 2018-2030 (USD Billion)
Fig. 31: Other end-use market, 2018-2030 (USD Billion)
Fig. 32: Clinical trial supplies market therapeutic use outlook key takeaways
Fig. 33: Clinical trial supplies market: Therapeutic Use movement analysis
Fig. 34: Oncology market, 2018-2030 (USD Billion)
Fig. 35: CNS market, 2018-2030 (USD Billion)
Fig. 36: Cardiovascular market, 2018-2030 (USD Billion)
Fig. 37: Infectious disease market, 2018-2030 (USD Billion)
Fig. 38: Metabolic disorders market, 2018-2030 (USD Billion)
Fig. 39: Other therapeutic use market, 2018-2030 (USD Billion)
Fig. 40: Regional marketplace: Key takeaways
Fig. 41: North America clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 42: U.S. clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 43: Canada clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 44: Europe clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 45: UK clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 46: Germany clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 47: France clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 48: Italy clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 49: Spain clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 50: Denmark clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 51: Sweden clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 52: Norway clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 53: Asia Pacific clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 54: Japan clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 55: China clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 56: India clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 57: Australia clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 58: South Korea clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 59: Thailand clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 60: Latin America clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 61: Brazil clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 62: Mexico clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 63: Argentina clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 64: MEA clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 65: South Africa clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 66: Saudi Arabia clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 67: UAE clinical trial supplies market, 2018-2030 (USD Billion)
Fig. 68: Kuwait clinical trial supplies market, 2018-2030 (USD Billion)

Companies Mentioned

  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Movianto
  • PCI Pharma Services
  • Sharp Services, LLC
  • Thermo Fisher Scientific, Inc.
  • Marken
  • Paraxel International Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages123
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.4 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 137 Pages
  • Global
From
Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Global Forecast 2025-2030 - Product Image

Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Clinical Trial Supplies Market by Phase, ????, Product, Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Clinical Trial Supplies Market by Phase, ????, Product, Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Clinical Trial Supplies Global Market Report 2024 - Product Image

Clinical Trial Supplies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area, End-Use Industry, and Region 2024-2032 - Product Image

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area, End-Use Industry, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.